98%
921
2 minutes
20
Objective: To compare neonatal outcomes for immediate pushing and delayed pushing in the second stage of labor in women receiving epidural analgesia.
Data Sources: Systematic searches in PubMed, EMBASE, Scopus, and CINAHL without restrictions by language, date of publication, or methodological quality.
Study Selection: The inclusion criteria were based on methodological and clinical factors such as population (pregnant women with epidural analgesia), intervention and control (delayed versus immediate pushing), neonatal outcomes, and study design (systematic reviews).
Data Extraction: The outcome measures were Apgar scores at 1 and 5 min, neonatal intensive care unit admission, prevalence of low umbilical artery cord pH, and umbilical artery cord pH. The methodological quality was analyzed using the Assessing the Methodological Study Tool for Systematic Reviews (AMSTAR) and Risk Of Bias In Systematic Reviews (ROBIS) scales, and the strength of evidence was established according to the Guidelines Advisory Committee grading criteria. For the umbilical artery cord pH variable, standardized mean differences and 95% confidence intervals were calculated and pooled in a meta-analysis using the random-effects model.
Data Synthesis: Seven systematic reviews with meta-analysis were included. The results suggest no difference between groups for Apgar test scores at 5 min, nor in the rate of neonatal intensive care unit admissions. Mixed results were found for delayed pushing leading to improvements in Apgar test scores at 1 min. No statistically significant between-group differences in the umbilical artery cord pH were found. The total duration of the second stage in the delayed pushing group was not significantly correlated with the umbilical artery cord pH.
Conclusions: Delayed pushing produces at least the same neonatal outcomes as immediate pushing in healthy pregnant women receiving epidural analgesia with a single fetus in vertex presentation with a limited quality of evidence. Review registered in the International Prospective Register of Systematic Reviews PROSPERO (CRD42023397616).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00404-025-08118-z | DOI Listing |
Diagn Pathol
August 2025
Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, Sichuan, China.
Background: Perivascular epithelioid cell tumor (PEComa) of the pancreas is a rare tumor of pancreatic mesenchymal origin with malignant potential. Critical to appropriate clinical management is determining whether the tumor is benign or malignant. Because of its rarity, morphologic and histologic characteristics and limited patient follow-up of pancreatic PEComa have precluded precise definition of malignancy.
View Article and Find Full Text PDFArch Gynecol Obstet
August 2025
Department of Physiotherapy, School of Physiotherapy, Universitat de València, Valencia, Spain.
Objective: To compare neonatal outcomes for immediate pushing and delayed pushing in the second stage of labor in women receiving epidural analgesia.
Data Sources: Systematic searches in PubMed, EMBASE, Scopus, and CINAHL without restrictions by language, date of publication, or methodological quality.
Study Selection: The inclusion criteria were based on methodological and clinical factors such as population (pregnant women with epidural analgesia), intervention and control (delayed versus immediate pushing), neonatal outcomes, and study design (systematic reviews).
Acta Neurochir (Wien)
July 2025
Institute of Neuroscience and Physiology, Section of Clinical Neuroscience, Sahlgrenska Academy, Gothenburg, Sweden.
Background: Proton radiation therapy (PRT) and mutant isocitrate dehydrogenase inhibitors (mIDH-inhibitors) are emerging therapies for mIDH lower grade gliomas (LGGs). Despite their substantial theoretical benefits, comparisons with current standards - particularly pertaining to patient-centred outcomes - are limited.
Methods: Through PubMed and Scopus, a search strategy based on keywords focusing on PRT and mIDH-inhibitors was applied on December 3, 2024.
Trials
July 2025
Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China.
Background: Amblyopia is a common developmental disorder with reduced visual acuity and impairment in binocular functions. Patching the fellow eye, as the gold standard therapy in amblyopia, sometimes fails to achieve satisfactory outcomes because of poor adherence or delayed intervention. Recently, dichoptic/binocular digital therapy in amblyopia has been developed, but no evidence-based binocular treatments with superiority are available.
View Article and Find Full Text PDF